Track topics on Twitter Track topics that are important to you
This initial consideration to Innovus common shareholders is estimated to consist of approximately 4.2 million shares of Aytu stock. Additional consideration for up to $16 million in milestone
The post Aytu BioScience to acquire Innovus Pharmaceuticals appeared first on Pharmaceutical Business review.
Original Article: Aytu BioScience to acquire Innovus PharmaceuticalsNEXT ARTICLE